Follow The Filings

CVKD Cadrenal Therapeutics

Cadrenal Therapeutics earnings company data as of 4:48 AM ET 10/23

  • 0 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS -0.95 -1.14 Miss
Rev — — —

Insider trades

Open-market buys and sales by CVKD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CVKD insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $542K sold by 2 insiders under 10b5-1 plans
  1. Quang X Pham CEO
    Planned sale
    $22K 7,400 shares at $3.03 7% of stake
    Traded Jun 29 Filed Jul 1
    ↗
  2. Quang X Pham CEO
    Planned sale
    $34K 11,156 shares at $3.04 9.5% of stake
    Traded Jun 25–26 Filed Jun 26
    ↗
  3. Quang X Pham CEO
    Planned sale
    $40K 11,444 shares at $3.48 8.9% of stake
    Traded Jun 22–23 Filed Jun 24
    ↗
  4. Quang X Pham CEO
    Planned sale
    $13K 4,126 shares at $3.18 3.1% of stake
    Traded Jun 16–17 Filed Jun 18
    ↗
  5. Quang X Pham CEO
    Planned sale
    $70K 18,124 shares at $3.88 12% of stake
    Traded Jun 11–15 Filed Jun 15
    ↗
  6. Quang X Pham CEO
    Planned sale
    $93K 22,385 shares at $4.17 13% of stake
    Traded Jun 8–10 Filed Jun 10
    ↗
  7. Quang X Pham CEO
    Planned sale
    $36K 8,285 shares at $4.37 4.6% of stake
    Traded Jun 3–5 Filed Jun 5
    ↗
  8. Quang X Pham CEO
    Planned sale
    $3,075 652 shares at $4.72 0.4% of stake
    Traded May 29–Jun 2 Filed Jun 2
    ↗
  9. Quang X Pham CEO
    Planned sale
    $69K 12,763 shares at $5.44 6.5% of stake
    Traded May 11–28 Filed May 29
    ↗
  10. Quang X Pham CEO
    Planned sale
    $6,629 1,165 shares at $5.69 0.6% of stake
    Traded May 22 Filed May 26
    ↗
  11. Matthew K Szot CFO
    Planned sale
    $69K 9,933 shares at $6.97 100% of stake
    Traded Dec 29, 2025 Filed Dec 31, 2025
    ↗
  12. Matthew K Szot CFO
    Planned sale
    $50K 3,600 shares at $13.99 27% of stake
    Traded Oct 24–27 Filed Oct 28, 2025
    ↗
  13. Quang X Pham CEO
    Planned sale
    $34K 2,444 shares at $14.01 1.2% of stake
    Traded Oct 24–27 Filed Oct 28, 2025
    ↗
  14. Quang X Pham CEO
    Planned sale
    $51K 3,600 shares at $14.09 1.8% of stake
    Traded Oct 9–13 Filed Oct 14, 2025
    ↗
  15. Matthew K Szot CFO
    Planned sale
    $49K 3,493 shares at $14.03 21% of stake
    Traded Oct 9–13 Filed Oct 14, 2025
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A PROXY STATEMENT Filing Doc
DEFA14A DEFINITIVE ADDITIONAL MATERIALS Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B3 PROSPECTUS Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 1.01,3.02,8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B3 PROSPECTUS Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc
8-K 1.01,3.02,3.03,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K ANNUAL REPORT Filing Doc
8-K 7.01,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.